Related Experiment Video
Updated: Jul 6, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
[Differences among dementias according to onset age: study based on dementia registry data]
J Vilalta-Franch1, J Garre-Olmo, S López-Pousa
1Unitat de Valoració de la Memòria i les demències (UVaMiD), UFISS programa Vida als Anys, Hospital Santa Caterina, Institut d'Assistència Sanitària, Girona. uvamid@ias.scs.es
Neurologia (Barcelona, Spain)
|March 29, 2008
Summary
Early-onset dementias present distinct clinical features and risk factors compared to late-onset forms. Understanding these differences is crucial for accurate dementia diagnosis and management.
Area of Science:
- Neurology
- Geriatrics
- Epidemiology
Context:
- Dementia diagnosis and management require understanding age-related differences.
- Differentiating dementias based on age of onset is critical for effective treatment.
Purpose:
- To identify cognitive, functional, and sociodemographic risk factors differentiating dementias by age of onset.
- To analyze clinical manifestations and risk factors in early-onset versus late-onset dementia.
Summary:
- A study of 670 dementia cases revealed that 10.3% had early-onset symptoms before age 66.
- Early-onset dementia showed a higher frequency of frontotemporal dementia, more behavioral issues, and a greater prevalence of Down's syndrome and depression history.
- Conversely, early-onset dementia patients exhibited less functional and cognitive impairment than late-onset cases, with no differences in vascular risk factors.
Impact:
- Early-onset dementias exhibit unique clinical profiles and risk factors, necessitating tailored diagnostic and therapeutic strategies.
- Dementia registries are valuable for studying less common disease characteristics and improving patient outcomes.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...